Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura J Esserman

Showing results (71-80 of 308) with videos related to

Pageof 31
Sort By:
JNCI Cancer Spectrum|July 31, 2019
The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic ApproachesMartin Eklund, Kristine Broglio, Christina Yau, et al.
AJR. American Journal of Roentgenology|February 16, 2018
Initial Clinical Experience With an Inducible Magnetic Seed System for Preoperative Breast Lesion LocalizationElissa R Price, Amal L Khoury, Laura J Esserman, et al.
Journal of the American College of Radiology : JACR|December 4, 2013
Evolving paradigm for imaging, diagnosis, and management of DCISColin J Wells, Cristina O'Donoghue, Haydee Ojeda-Fournier, et al.
Annals of Surgical Oncology|June 20, 2013
Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)Rita A Mukhtar, Christina Yau, Mark Rosen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 9, 2020
The Evolution of Our Understanding of the Biology of Cancer Is the Key to Avoiding Overdiagnosis and OvertreatmentKelly Hewitt, Jennifer Son, Alexa Glencer, et al.
NPJ Breast Cancer|June 27, 2019
A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxelSorbarikor Piawah, Colby Hyland, Sarah E Umetsu, et al.
AJR. American Journal of Roentgenology|October 22, 2002
Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapySavannah C Partridge, Jessica E Gibbs, Ying Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2011
Leukocyte composition of human breast cancerBrian Ruffell, Alfred Au, Hope S Rugo, et al.
Nature Reviews. Clinical Oncology|April 14, 2016
Population-based screening for cancer: hope and hypeYiwey Shieh, Martin Eklund, George F Sawaya, et al.
Annals of Surgical Oncology|May 22, 2015
Comparison of Mammographic Findings Following Oncoplastic Mammoplasty and Lumpectomy Without ReconstructionMerisa Piper, Anne Warren Peled, Hani Sbitany, et al.
Pageof 31

Showing results (71-80 of 308) with videos related to

Sort By:
Pageof 31
JNCI Cancer Spectrum|July 31, 2019
The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic ApproachesMartin Eklund, Kristine Broglio, Christina Yau, et al.
AJR. American Journal of Roentgenology|February 16, 2018
Initial Clinical Experience With an Inducible Magnetic Seed System for Preoperative Breast Lesion LocalizationElissa R Price, Amal L Khoury, Laura J Esserman, et al.
Journal of the American College of Radiology : JACR|December 4, 2013
Evolving paradigm for imaging, diagnosis, and management of DCISColin J Wells, Cristina O'Donoghue, Haydee Ojeda-Fournier, et al.
Annals of Surgical Oncology|June 20, 2013
Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)Rita A Mukhtar, Christina Yau, Mark Rosen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 9, 2020
The Evolution of Our Understanding of the Biology of Cancer Is the Key to Avoiding Overdiagnosis and OvertreatmentKelly Hewitt, Jennifer Son, Alexa Glencer, et al.
NPJ Breast Cancer|June 27, 2019
A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxelSorbarikor Piawah, Colby Hyland, Sarah E Umetsu, et al.
AJR. American Journal of Roentgenology|October 22, 2002
Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapySavannah C Partridge, Jessica E Gibbs, Ying Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2011
Leukocyte composition of human breast cancerBrian Ruffell, Alfred Au, Hope S Rugo, et al.
Nature Reviews. Clinical Oncology|April 14, 2016
Population-based screening for cancer: hope and hypeYiwey Shieh, Martin Eklund, George F Sawaya, et al.
Annals of Surgical Oncology|May 22, 2015
Comparison of Mammographic Findings Following Oncoplastic Mammoplasty and Lumpectomy Without ReconstructionMerisa Piper, Anne Warren Peled, Hani Sbitany, et al.
Pageof 31